Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 106,031 shares of Arteris stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $17.21, for a total value of $1,824,793.51. Following the completion of the sale, the director directly owned 393,690 shares in the company, valued at $6,775,404.90. This represents a 21.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Saiyed Atiq Raza also recently made the following trade(s):
- On Wednesday, March 4th, Saiyed Atiq Raza sold 3,690 shares of Arteris stock. The stock was sold at an average price of $17.02, for a total value of $62,803.80.
- On Friday, February 27th, Saiyed Atiq Raza sold 11,762 shares of Arteris stock. The shares were sold at an average price of $17.01, for a total value of $200,071.62.
- On Thursday, February 26th, Saiyed Atiq Raza sold 73,610 shares of Arteris stock. The shares were sold at an average price of $17.14, for a total value of $1,261,675.40.
- On Wednesday, February 25th, Saiyed Atiq Raza sold 4,907 shares of Arteris stock. The stock was sold at an average price of $17.00, for a total value of $83,419.00.
Arteris Stock Up 1.7%
Shares of AIP opened at $16.46 on Thursday. Arteris, Inc. has a twelve month low of $5.46 and a twelve month high of $19.85. The stock has a market capitalization of $748.44 million, a P/E ratio of -20.07 and a beta of 1.45. The company has a 50 day moving average of $15.90 and a 200-day moving average of $13.81.
Arteris (NASDAQ:AIP - Get Free Report) last announced its earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The business had revenue of $20.14 million for the quarter, compared to analyst estimates of $18.55 million. On average, sell-side analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.
Institutional Trading of Arteris
Hedge funds have recently modified their holdings of the stock. Westerly Capital Management LLC grew its stake in Arteris by 109.6% in the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company's stock valued at $14,392,000 after buying an additional 745,000 shares during the last quarter. Nuveen LLC boosted its holdings in shares of Arteris by 872.3% during the fourth quarter. Nuveen LLC now owns 737,281 shares of the company's stock worth $11,428,000 after acquiring an additional 661,454 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Arteris by 144.7% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company's stock worth $15,696,000 after purchasing an additional 598,840 shares during the period. Granahan Investment Management LLC increased its stake in shares of Arteris by 725.7% during the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company's stock worth $6,278,000 after purchasing an additional 546,341 shares during the period. Finally, Informed Momentum Co LLC bought a new stake in Arteris in the 4th quarter valued at $5,755,000. Institutional investors and hedge funds own 64.36% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on the company. TD Cowen reaffirmed a "buy" rating on shares of Arteris in a research report on Wednesday, November 5th. Weiss Ratings restated a "sell (d-)" rating on shares of Arteris in a report on Wednesday, January 21st. Northland Securities set a $24.00 price target on shares of Arteris in a research report on Friday, February 13th. Finally, Rosenblatt Securities reissued a "buy" rating and issued a $20.00 price objective on shares of Arteris in a research report on Friday, February 13th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $20.17.
Check Out Our Latest Analysis on AIP
Arteris Company Profile
(
Get Free Report)
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
